Brigitte C Widemann, M.D.
Rare Disease Specialist
National Cancer Institute (NCI)
Bethesda, Maryland
PI on 18 trials
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
- Multiple non-ossifying fibromatosis
- Multiple endocrine neoplasia type 2A
- Gastrointestinal stromal tumor
- Optic pathway glioma
- Genetic soft tissue tumor
- Genetic cranial malformation
- Genetic eye tumor
- Malignant peripheral nerve sheath tumor
- Hereditary neurocutaneous malformation
- BAP1-related tumor predisposition syndrome
- Bone sarcoma
- Neurofibroma
- Genetic neurodegenerative disease
- Rare soft tissue tumor
- Fibrosarcoma
- Rare bone tumor
- Genetic neuromuscular disease
- Neurofibromatosis type 1
- Multiple endocrine neoplasia type 2B
- Genetic renal tumor
- Rare nervous system tumor
Clinical trials (18)
Verify independently
Other specialists for Multiple non-ossifying fibromatosis
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Brigitte C. Widemann, MD, M.DNational Cancer Institute (NCI)MD
- Prashant Chittiboina, M.D.National Institute of Neurological Disorders and Stroke (NINDS)Maryland
- Donald Gilbert, MD MSChildren's Hospital Medical Center, CincinnatiOhio
- Vanessa Merker, PhDMassachusetts General HospitalMassachusetts
- Scott Plotkin, MD, PhD, M.DMassachusetts General HospitalNY
- Dusica Babovic-Vuksanovic, MD, M.DMayo ClinicMN
- John D Heiss, M.D., M.DNational Institute of Neurological Disorders and Stroke (NINDS)MD
- Qingfeng LiShanghai Ninth People's Hospital affiliated to Shanghai JiaoTong University
See all specialists for Multiple non-ossifying fibromatosis →